Rebiotix Patents – Insights & Stats (Updated 2023)

Rebiotix has a total of 142 patents globally, out of which 83 have been granted. Of these 142 patents, more than 78% patents are active. The United States of America is where Rebiotix has filed the maximum number of patents, followed by Australia and Europe (EPO). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Rebiotix.

Rebiotix was founded in 2011. Rebiotix is a development-stage biotechnology company focusing on the treatment of GI diseases by developing human microbiome.

Do read about some of the most popular patents of Rebiotix which have been covered by us in this article and also you can find Rebiotix patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Rebiotix patent portfolio.

How many patents does Rebiotix have?

Rebiotix has a total of 142 patents globally. These patents belong to 18 unique patent families. Out of 142 patents, 112 patents are active.

How Many Patents did Rebiotix File Every Year?

Rebiotix Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantRebiotix Applications FiledRebiotix Patents Granted
202315
2022516
2021411
20201013
2019914
2018169
2017258
2016225
201552
201426

How many Rebiotix patents are Alive/Dead?

Worldwide Patents

Rebiotix Patent Portfolio

How Many Patents did Rebiotix File in Different Countries?

Rebiotix Worldwide Patent Filing

Countries in which Rebiotix Filed Patents

CountryPatent
United States of America40
Australia15
Europe (EPO)12
Korea (South)9
Hong Kong (S.A.R.)8
Canada7
China6
Spain5
Israel5
Japan4
Russian Federation3
Poland3
Hungary2
Brazil2
Denmark2
Croatia2
Slovenia2
Lithuania2
Turkey2
Mexico2
Portugal2
India1
Serbia1

Where are Research Centers of Rebiotix Patents Located?

The Research Centers of Rebiotix Patents is the United States of America.

10 Best Rebiotix Patents

US9433651B2 is the most popular patent in the Rebiotix portfolio. It has received 69 citations so far from companies like uBiome, Psomagen, Prolacta Bioscience.

Below is the list of 10 most cited patents of Rebiotix:

Publication NumberCitation Count
US9433651B269
WO2014197562A138
WO2016201114A114
US9675648B211
US20140363400A111
US10226431B29
US9629881B27
CN107921072A7
US10828340B26
US9511099B26

What Percentage of Rebiotix US Patent Applications Were Granted?

Rebiotix (Excluding its subsidiaries) has filed 12 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 10 have been granted leading to a grant rate of 83.33%.

Below are the key stats of Rebiotix patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Rebiotix?

Law FirmTotal ApplicationsSuccess Rate
Foley & Lardner Llp1190.91%
Seager Tufte & Wickhem Llp10%

What are Rebiotix key innovation segments?

What Technologies are Covered by Rebiotix?

The chart below distributes patents filed by Rebiotix in different countries on the basis of the technology protected in patents. It also represents the markets where Rebiotix thinks it’s important to protect particular technology inventions.

R&D Focus: How has Rebiotix search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Rebiotix?

Related Articles

VoxelSensors Patents – Insights & Stats (Updated 2024)

VoxelSensors has a total of 36 patents globally, out of which 8 have been granted. Of these 36 patents, more than 94% patents are active. Europe (EPO) is where VoxelSensors has filed the maximum number of patents, followed by China and Israel. Parallelly, Belgium seems to be the main focused

Read More »

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.